Abstract: The present invention provides methods for treating cancer in a subject, comprising administering to the subject an effective amount of a combination of andrographolide and melatonin. The present invention further provides compositions comprising effective amounts of andrographolide and melatonin for treating cancer.
Type:
Grant
Filed:
April 30, 2021
Date of Patent:
March 31, 2026
Assignees:
UNIVERSITY OF MARYLAND, BALTIMORE, GLYCOMANTRA INC.
Inventors:
Aditi Banerjee, Steven Czinn, Hafiz Ahmed, Thomas Blanchard
Abstract: A method of treating a metabolic disorder includes identifying a subject having a metabolic disorder and administering to the subject a therapeutically effective amount of GM201, wherein the therapeutically effective amount is between 0.1 mg/kg and 500 mg/kg with respect to a body weight of the subject.
Abstract: A method of treating a metabolic disorder includes identifying a subject having a metabolic disorder and administering to the subject a therapeutically effective amount of GM201, wherein the therapeutically effective amount is between 0.1 mg/kg and 500 mg/kg with respect to a body weight of the subject.
© 2026 Justia
